The tumor suppressive role of eIF3f and its function in translation inhibition and rRNA degradation

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Wen, Fushi ^a   Zhou, Renyuan ^b   Shen, Alex ^a   Choi, Andrew ^a   Uribe, Diana ^a   Shi, Jiaqi ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b Urology Institute of Fudan University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; ETOPOSIDE; GEMCITABINE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; INITIATION FACTOR; INITIATION FACTOR 3F; RIBOSOME RNA; UNCLASSIFIED DRUG; EIF3I PROTEIN, HUMAN; INITIATION FACTOR 3; PRIMER DNA;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CELL SIZE; CLONOGENESIS; CONTROLLED STUDY; CYTOKINESIS; CYTOPLASM; DRUG RESISTANCE; EPITHELIUM CELL; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; PANCREAS CANCER; PANCREAS DUCT; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RNA DEGRADATION; RNA STABILITY; RNA TRANSLATION; TRANSLATION INHIBITION; TRANSLATION REGULATION; TUMOR PROMOTION; GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

EUKARYOTA; MAMMALIA;

BASE SEQUENCE; CELL LINE, TUMOR; DNA PRIMERS; EUKARYOTIC INITIATION FACTOR-3; GENES, TUMOR SUPPRESSOR; HUMANS; PROTEIN BIOSYNTHESIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL;

EID: 84858767569     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034194     Document Type: Article

References (47)

1. Bilanges B, Stokoe D, (2007) Mechanisms of translational deregulation in human tumors and therapeutic intervention strategies. Oncogene 26: 5973-5990.
2. Sonenberg N, Hinnebusch AG, (2009) Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 136: 731-745.
3. Dong Z, Zhang JT, (2006) Initiation factor eIF3 and regulation of mRNA translation, cell growth, and cancer. Crit Rev Oncol Hematol 59: 169-180.
4. Watkins SJ, Norbury CJ, (2002) Translation initiation and its deregulation during tumorigenesis. Br J Cancer 86: 1023-1027.
5. Joseph P, Lei YX, Whong WZ, Ong TM, (2002) Molecular cloning and functional analysis of a novel cadmium-responsive proto-oncogene. Cancer Res 62: 703-707.
6. Shi J, Kahle A, Hershey JW, Honchak BM, Warneke JA, et al. (2006) Decreased expression of eukaryotic initiation factor 3f deregulates translation and apoptosis in tumor cells. Oncogene 25: 4923-4936.
7. Zhang L, Pan X, Hershey JW, (2007) Individual overexpression of five subunits of human translation initiation factor eIF3 promotes malignant transformation of immortal fibroblast cells. J Biol Chem 282: 5790-5800.
8. Shi J, Feng Y, Goulet AC, Vaillancourt RR, Sachs NA, et al. (2003) The p34cdc2-related cyclin-dependent kinase 11 interacts with the p47 subunit of eukaryotic initiation factor 3 during apoptosis. J Biol Chem 278: 5062-5071.
9. Doldan A, Chandramouli A, Shanas R, Bhattacharyya A, Cunningham JT, et al. (2008) Loss of the eukaryotic initiation factor 3f in pancreatic cancer. Mol Carcinog 47: 235-244.
10. Doldan A, Chandramouli A, Shanas R, Bhattacharyya A, Leong SP, et al. (2008) Loss of the eukaryotic initiation factor 3f in melanoma. Mol Carcinog 47: 806-813.
11. White RJ, (2008) RNA polymerases I and III, non-coding RNAs and cancer. Trends Genet 24: 622-629.
12. Wen F, Shen A, Shanas R, Bhattacharyya A, Lian F, et al. (2010) Higher expression of the heterogeneous nuclear ribonucleoprotein k in melanoma. Ann Surg Oncol 17: 2619-2627.
13. Zhou R, Shanas R, Nelson MA, Bhattacharyya A, Shi J, (2009) Increased expression of the heterogeneous nuclear ribonucleoprotein K in pancreatic cancer and its association with the mutant p53. Int J Cancer 126: 395-404.
14. Skalweit A, Doller A, Huth A, Kahne T, Persson PB, et al. (2003) Posttranscriptional control of renin synthesis: identification of proteins interacting with renin mRNA 3′-untranslated region. Circ Res 92: 419-427.
15. Paziewska A, Wyrwicz LS, Ostrowski J, (2005) The binding activity of yeast RNAs to yeast Hek2p and mammalian hnRNP K proteins, determined using the three-hybrid system. Cell Mol Biol Lett 10: 227-235.
16. Ouyang H, Mou L, Luk C, Liu N, Karaskova J, et al. (2000) Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype. Am J Pathol 157: 1623-1631.
17. Shi J, Hershey JW, Nelson MA, (2009) Phosphorylation of the eukaryotic initiation factor 3f by cyclin-dependent kinase 11 during apoptosis. FEBS Lett 583: 971-977.
18. Rodriguez AJ, Condeelis J, Singer RH, Dictenberg JB, (2007) Imaging mRNA movement from transcription sites to translation sites. Semin Cell Dev Biol 18: 202-208.
19. Peng XH, Cao ZH, Xia JT, Carlson GW, Lewis MM, et al. (2005) Real-time detection of gene expression in cancer cells using molecular beacon imaging: new strategies for cancer research. Cancer Res 65: 1909-1917.
20. Evans JR, Mitchell SA, Spriggs KA, Ostrowski J, Bomsztyk K, et al. (2003) Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo. Oncogene 22: 8012-8020.
21. Zhu Y, Denhardt DT, Cao H, Sutphin PD, Koong AC, et al. (2005) Hypoxia upregulates osteopontin expression in NIH-3T3 cells via a Ras-activated enhancer. Oncogene 24: 6555-6563.
22. Vascotto C, Fantini D, Romanello M, Cesaratto L, Deganuto M, et al. (2009) APE1/Ref-1 interacts with NPM1 within nucleoli and plays a role in the rRNA quality control process. Mol Cell Biol 29: 1834-1854.
23. Zhou R, Shanas R, Nelson MA, Bhattacharyya A, Shi J, (2010) Increased expression of the heterogeneous nuclear ribonucleoprotein K in pancreatic cancer and its association with the mutant p53. Int J Cancer 126: 395-404.
24. Ariza ME, Broome-Powell M, Lahti JM, Kidd VJ, Nelson MA, (1999) Fas-induced apoptosis in human malignant melanoma cell lines is associated with the activation of the p34(cdc2)-related PITSLRE protein kinases. J Biol Chem 274: 28505-28513.
25. Debnath J, Muthuswamy SK, Brugge JS, (2003) Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30: 256-268.
26. Mikolajczyk M, Nelson MA, (2004) Regulation of stability of cyclin-dependent kinase CDK11p110 and a caspase-processed form, CDK11p46, by Hsp90. Biochem J 384: 461-467.
27. Liu N, Furukawa T, Kobari M, Tsao MS, (1998) Comparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinoma. Am J Pathol 153: 263-269.
28. Barna M, Pusic A, Zollo O, Costa M, Kondrashov N, et al. (2008) Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency. Nature 456: 971-975.
29. Fitzgerald KD, Semler BL, (2009) Bridging IRES elements in mRNAs to the eukaryotic translation apparatus. Biochim Biophys Acta 1789: 518-528.
30. Cornelis S, Bruynooghe Y, Denecker G, Van Huffel S, Tinton S, et al. (2000) Identification and characterization of a novel cell cycle-regulated internal ribosome entry site. Mol Cell 5: 597-605.
31. Petretti C, Savoian M, Montembault E, Glover DM, Prigent C, et al. (2006) The PITSLRE/CDK11p58 protein kinase promotes centrosome maturation and bipolar spindle formation. EMBO Rep 7: 418-424.
32. Csibi A, Cornille K, Leibovitch MP, Poupon A, Tintignac LA, et al. The translation regulatory subunit eIF3f controls the kinase-dependent mTOR signaling required for muscle differentiation and hypertrophy in mouse. PLoS One 5: e8994.
33. Lagirand-Cantaloube J, Offner N, Csibi A, Leibovitch MP, Batonnet-Pichon S, et al. (2008) The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy. Embo J 27: 1266-1276.
34. Frescas D, Guardavaccaro D, Bassermann F, Koyama-Nasu R, Pagano M, (2007) JHDM1B/FBXL10 is a nucleolar protein that represses transcription of ribosomal RNA genes. Nature 450: 309-313.
35. Grandori C, Gomez-Roman N, Felton-Edkins ZA, Ngouenet C, Galloway DA, et al. (2005) c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nat Cell Biol 7: 311-318.
36. Grewal SS, Evans JR, Edgar BA, (2007) Drosophila TIF-IA is required for ribosome synthesis and cell growth and is regulated by the TOR pathway. J Cell Biol 179: 1105-1113.
37. Cole SE, LaRiviere FJ, Merrikh CN, Moore MJ, (2009) A convergence of rRNA and mRNA quality control pathways revealed by mechanistic analysis of nonfunctional rRNA decay. Mol Cell 34: 440-450.
38. Buchan JR, Parker R, (2009) Eukaryotic stress granules: the ins and outs of translation. Mol Cell 36: 932-941.
39. Moser JJ, Fritzler MJ, (2010) Cytoplasmic ribonucleoprotein (RNP) bodies and their relationship to GW/P bodies. Int J Biochem Cell Biol 42: 828-843.
40. Fukuda T, Naiki T, Saito M, Irie K, (2009) hnRNP K interacts with RNA binding motif protein 42 and functions in the maintenance of cellular ATP level during stress conditions. Genes Cells 14: 113-128.
41. Tyagi S, Alsmadi O, (2004) Imaging native beta-actin mRNA in motile fibroblasts. Biophys J 87: 4153-4162.
42. Marchetti A, Buttitta F, Pellegrini S, Bertacca G, Callahan R, (2001) Reduced expression of INT-6/eIF3-p48 in human tumors. Int J Oncol 18: 175-179.
43. Morley SJ, McKendrick L, Bushell M, (1998) Cleavage of translation initiation factor 4G (eIF4G) during anti-Fas IgM-induced apoptosis does not require signalling through the p38 mitogen-activated protein (MAP) kinase. FEBS Lett 438: 41-48.
44. Clemens MJ, Bushell M, Morley SJ, (1998) Degradation of eukaryotic polypeptide chain initiation factor (eIF) 4G in response to induction of apoptosis in human lymphoma cell lines. Oncogene 17: 2921-2931.
45. Wallach D, (1997) Cell death induction by TNF: a matter of self control. Trends Biochem Sci 22: 107-109.
46. Sheikh MS, Fornace AJ Jr, (1999) Regulation of translation initiation following stress. Oncogene 18: 6121-6128.
47. Hanahan D, Weinberg RA, (2000) The hallmarks of cancer. Cell 100: 57-70.